Enterprise Financial Services Corp Exact Sciences Corp Transaction History

Enterprise Financial Services Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$90.24 - $124.05 $3,068 - $4,217	-34 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$93.66 - $139.27 $280 - $417	3 Added 9.68%	34 $4,000
Q4 2020 Feb 12, 2021	BUY	$99.61 - $142.12 $1,494 - $2,131	15 Added 93.75%	31 $4,000
Q2 2020 Aug 04, 2020	BUY	$55.75 - $92.75 $892 - $1,484	16 New	16 $1,000
Q4 2019 Jan 28, 2020	SELL	$77.66 - $99.74 $854 - $1,097	-11 Closed	0 $0
Q1 2019 Apr 26, 2019	BUY	$61.98 - $96.5 $681 - $1,061	11 New	11 $1,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.5B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

Stay updated on Enterprise Financial Services Corp with notifications on news.